UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Unexpectedly rapid evolution of mandibular shape in hominins

Scientific reports, 2018-05, Vol.8 (1), p.7340-8, Article 7340

2018

Volltextzugriff (PDF)

746 PROSPECTIVE VALIDATION OF 2010 AASLD GUIDELINE FOR THE DIAGNOSIS OF 1-2 CM HCC IN CIRRHOTIC PATIENTS

Journal of hepatology, 2012-04, Vol.56, p.S293-S294

2012

Volltextzugriff (PDF)

P.06.26 POSITIVE EFFECT OF “FLAVOURED ICED DESSERT” ON DIGESTION PERCEPTION AND GASTRIC EMPTYING TIME IN HEALTY NON DYSPEPTIC VOLUNTEERS

Digestive and liver disease, 2013-03, Vol.45, p.S135-S135

2013

Volltextzugriff (PDF)

The impact of IL-28B polymorphism and diabetes on SVR after antiviral therapy (AT) for post-liver transplant (LT) HCV recurrence

Digestive and liver disease, 2014-02, Vol.46, p.e41-e41

2014

Volltextzugriff (PDF)

578 IS THE PRIMARY IMMUNOSUPPRESSIVE DRUG (CYCLOSPORIN A OR TACROLIMUS) PLAYING A ROLE ON THE RESPONSE TO ANTIVIRAL TREATMENT FOR POST-TRANSPLANT HCV RECURRENCE?

Journal of hepatology, 2011-03, Vol.54, p.S235-S235

2011

Volltextzugriff (PDF)

579 THE PRESENCE OF DIABETES REDUCES SVR AFTER ANTIVIRAL THERAPY FOR POST-TRANSPLANT HCV RECURRENCE

Journal of hepatology, 2011-03, Vol.54, p.S236-S236

2011

Volltextzugriff (PDF)

P.13.8 THE IMPACT OF BASELINE CHARACTERISTICS ON THE SURVIVAL IN A COHORT OF 270 PATIENTS WITH HEPATOCELLULAR CARCINOMA TREATED WITH TRANSARTERIAL CHEMOEMBOLIZATION: A SINGLE CENTER STUDY

Digestive and liver disease, 2013-03, Vol.45, p.S184-S184

2013

Volltextzugriff (PDF)

Fatty liver and drugs

European review for medical and pharmacological sciences, 2005-09, Vol.9 (5), p.261

2005

Volltextzugriff (PDF)

F-40 The impact of baseline characteristics on the survival in a cohort of 270 patients with hepatocellular carcinoma treated with transarterial chemoembolization: a single center study

Digestive and liver disease, 2013-02, Vol.45, p.S43-S43

2013

Volltextzugriff (PDF)

P.03.6 IS THE PRIMARY IMMUNOSUPPRESSIVE DRUG (CYCLOSPORIN A OR TACROLIMUS) PLAYING A ROLE ON THE RESPONSE TO ANTIVIRAL TREATMENT FOR POST-TRANSPLANT HCV RECURRENCE?

Digestive and liver disease, 2012-03, Vol.44, p.S101-S101

2012

Volltextzugriff (PDF)

F-5 Prospective validation of 2010 AASLD guideline for the diagnosis of 1-2 cm HCC in cirrhotic patients

Digestive and liver disease, 2012-02, Vol.44, p.S33-S33

2012

Volltextzugriff (PDF)

P.04.9 THE PRESENCE OF DIABETES REDUCES SVR AFTER ANTIVIRAL THERAPY FOR POST-TRANSPLANT HCV RECURRENCE

Digestive and liver disease, 2012-03, Vol.44, p.S108-S108

2012

Volltextzugriff (PDF)

P.04.4 SVR TO ANTIVIRAL TREATMENT FOR POST-OLT RECURRENT HCV HEPATITIS CAN BE IMPROVED BY THE USE OF GROWTH FACTORS

Digestive and liver disease, 2012-03, Vol.44, p.S106-S106

2012

Volltextzugriff (PDF)

Non-selective beta-blockers lower the risk of first decompensation in patients with cirrhosis and enduring clinically significant portal hypertension after etiological treatment

Digestive and liver disease, 2024-02, Vol.56, p.S2

2024

Volltextzugriff (PDF)

F-39 Is the primary immunosuppressive drug playing a role on the response to antiviral treatment for post-transplant HCV recurrence?

Digestive and liver disease, 2011, Vol.43, p.S104-S104

2011

Volltextzugriff (PDF)

Evolution of the sabertooth mandible: A deadly ecomorphological specialization

Palaeogeography, palaeoclimatology, palaeoecology, 2018-05, Vol.496, p.166-174

2018

Volltextzugriff (PDF)

Nutritional aspects in patients with non-alcoholic steatohepatitis (NASH)

European review for medical and pharmacological sciences, 2005-09, Vol.9 (5), p.265

2005

Volltextzugriff (PDF)

Living with the elephant in the room: Top-down control in Eurasian large mammal diversity over the last 22 million years

Palaeogeography, palaeoclimatology, palaeoecology, 2017-11, Vol.485, p.956-962

2017

Volltextzugriff (PDF)

The treatment of hepatocellular carcinoma: an update

Minerva medica, 2009-06, Vol.100 (3), p.173

2009

Volltextzugriff (PDF)

Role of serum sodium as predictor of survival for “intermediate HCC” treated with transarterial chemioembolization (TACE)

Digestive and liver disease, 2009, Vol.41 (5), p.A17-A18

2009

Volltextzugriff (PDF)

Nonalcoholic fatty liver disease: defining a common problem

European review for medical and pharmacological sciences, 2005-09, Vol.9 (5), p.253

2005

Volltextzugriff (PDF)

The natural history and risk factors for progression of non-alcoholic fatty liver disease and steatohepatitis

European review for medical and pharmacological sciences, 2005-09, Vol.9 (5), p.273

2005

Volltextzugriff (PDF)

[736] GENETIC AND ENVIRONMENTAL FACTORS RESPONSIBLE FOR OXIDATIVE STRESS IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)

Journal of hepatology, 2007, Vol.46, p.S277-S277

2007

Volltextzugriff (PDF)

PA.92 A PROPOSAL MODEL FOR THE NON-INVASIVE ASSESSMENT OF HISTOLOGICAL INFLAMMATION IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)

Digestive and liver disease, 2008, Vol.40, p.S108-S109

2008

Volltextzugriff (PDF)

1 – 25 von 102

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(85)
Mit Volltextzugriff
(85)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(52)
Life Sciences & Biomedicine
(27)
Physical Sciences
(21)
Gastroenterology And Hepatology
(19)
Humans
(13)
Physics
(13)
Technology
(13)
Exact Sciences And Technology
(10)
Pulsed Laser Deposition
(10)
Biological And Medical Sciences
(9)
Male
(8)
Materials Science
(8)
Fundamental And Applied Biological Sciences. Psychology
(7)
Physics, Applied
(7)
Female
(6)
Superconductivity
(6)
Aged
(5)
Animals
(5)
Bscco
(5)
Engineering
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Unexpectedly rapid evolution of mandibular shape in hominins

746 PROSPECTIVE VALIDATION OF 2010 AASLD GUIDELINE FOR THE DIAGNOSIS OF 1-2 CM HCC IN CIRRHOTIC PATIENTS

P.06.26 POSITIVE EFFECT OF “FLAVOURED ICED DESSERT” ON DIGESTION PERCEPTION AND GASTRIC EMPTYING TIME IN HEALTY NON DYSPEPTIC VOLUNTEERS

The impact of IL-28B polymorphism and diabetes on SVR after antiviral therapy (AT) for post-liver transplant (LT) HCV recurrence

Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C

578 IS THE PRIMARY IMMUNOSUPPRESSIVE DRUG (CYCLOSPORIN A OR TACROLIMUS) PLAYING A ROLE ON THE RESPONSE TO ANTIVIRAL TREATMENT FOR POST-TRANSPLANT HCV RECURRENCE?

579 THE PRESENCE OF DIABETES REDUCES SVR AFTER ANTIVIRAL THERAPY FOR POST-TRANSPLANT HCV RECURRENCE

P.13.8 THE IMPACT OF BASELINE CHARACTERISTICS ON THE SURVIVAL IN A COHORT OF 270 PATIENTS WITH HEPATOCELLULAR CARCINOMA TREATED WITH TRANSARTERIAL CHEMOEMBOLIZATION: A SINGLE CENTER STUDY

Fatty liver and drugs

F-40 The impact of baseline characteristics on the survival in a cohort of 270 patients with hepatocellular carcinoma treated with transarterial chemoembolization: a single center study

P.03.6 IS THE PRIMARY IMMUNOSUPPRESSIVE DRUG (CYCLOSPORIN A OR TACROLIMUS) PLAYING A ROLE ON THE RESPONSE TO ANTIVIRAL TREATMENT FOR POST-TRANSPLANT HCV RECURRENCE?

F-5 Prospective validation of 2010 AASLD guideline for the diagnosis of 1-2 cm HCC in cirrhotic patients

P.04.9 THE PRESENCE OF DIABETES REDUCES SVR AFTER ANTIVIRAL THERAPY FOR POST-TRANSPLANT HCV RECURRENCE

P.04.4 SVR TO ANTIVIRAL TREATMENT FOR POST-OLT RECURRENT HCV HEPATITIS CAN BE IMPROVED BY THE USE OF GROWTH FACTORS

Non-selective beta-blockers lower the risk of first decompensation in patients with cirrhosis and enduring clinically significant portal hypertension after etiological treatment

F-39 Is the primary immunosuppressive drug playing a role on the response to antiviral treatment for post-transplant HCV recurrence?

Evolution of the sabertooth mandible: A deadly ecomorphological specialization

Nutritional aspects in patients with non-alcoholic steatohepatitis (NASH)

Living with the elephant in the room: Top-down control in Eurasian large mammal diversity over the last 22 million years

The treatment of hepatocellular carcinoma: an update

Role of serum sodium as predictor of survival for “intermediate HCC” treated with transarterial chemioembolization (TACE)

Nonalcoholic fatty liver disease: defining a common problem

The natural history and risk factors for progression of non-alcoholic fatty liver disease and steatohepatitis

[736] GENETIC AND ENVIRONMENTAL FACTORS RESPONSIBLE FOR OXIDATIVE STRESS IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)

PA.92 A PROPOSAL MODEL FOR THE NON-INVASIVE ASSESSMENT OF HISTOLOGICAL INFLAMMATION IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)

Suchergebnisse filtern